Company intelligence
Co-Labb
Transforming science into story | Scientific writing and medical communications that empower life science companies.
About Co-Labb
Co-Labb | Transforming Science into Story Co-Labb transforms complex science into clear, impactful communications for the Pharma, Biotech, MedTech, and Healthcare sectors. Our team of exclusively PhD-level writers delivers tailored solutions for startups, scale-ups, and global leaders alike. What We Do From regulatory submissions to content marketing campaigns, we support every stage of your product lifecycle: - Regulatory Writing: Clinical trial protocols, IND/NDA applications and more. - Manuscript Writing: High-impact, peer-reviewed publications. - Scientific Copywriting: SEO blogs, white papers, and product materials. - Content Strategy: Campaigns that engage audiences and drive results. Why Co-Labb? We’re more than a writing agency—we’re your scientific partner. Our clients trust us to deliver accurate, on-brand content on time, so you can focus on innovation while we handle the communication. Clarity in every word. Impact in every result.
Verified activity
Signals from Co-Labb
2 published signals
Research & Knowledge
Co-Labb published a study in Nature Communications by researchers from the University of Illinois and Auburn University investigating whether bacteria isolated from urine samples collected from men prior to prostate biopsy could alter androgen metabolism and influence prostate cancer biology.
Reported by Co-Labb
Research & Knowledge
Co-Labb published a large real-world study led by Flinders University and Flinders Medical Centre analyzing data from 1,691 Australians with bowel cancer that had spread to the liver.
Reported by Co-Labb